Carcinoma, Ductal, Breast clinical trials at UC Health
2 research studies open to new patients
open to eligible females ages 18 years and up
Phase 2, open-label study of AVB-620 in women with primary, nonrecurrent and nonmetastatic breast cancer undergoing surgery.
open to eligible people ages 12 years and up
Phase II, multi-center, open-label study of patients with advanced solid tumors harboring a fusion of NTRK1, NTRK2 or NTRK3.